Araris Biotech

About:

Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.

Website: https://www.ararisbiotech.com

Top Investors: Venture Kick, redalpine, Samsung Ventures, Schroders Capital, Wille Finance

Description:

Araris Biotech AG (Araris) is a biotechnology start-up company. Their aim is to deliver a breakthrough technology platform that enables the development of next-generation ADC-based safe and potent drugs for various diseases and ailments.They are committed to produce high quality ADCs that do not require any engineering (antibody and/or cell-line) for site-specific conjugation instead the antibodies can directly be taken 'off-the-shelf'. The site-specifically modified ADCs can thus be produced rapidly within a few days and quality control and analysis can be performed quickly with high confidence. Their ADC technology is backed by two patents.